Xencor Inc
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
XNCR$39.39+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(in thousands)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(85,484) | $(190,340) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 7,935 | 9,113 |
| Accretion of discount on marketable debt securities, net | (3,141) | (16,635) |
| Stock-based compensation | 33,042 | 40,949 |
| Gain on sale of marketable securities, net | (4,973) | (3) |
| Change in fair value of marketable equity securities | (45,136) | 448 |
| Asset impairment charges | 8,288 | 20,430 |
| Non-cash royalty revenue related to the sale of future royalties | (57,828) | (48,646) |
| Non-cash interest expense on liabilities related to the sale of future royalties | 24,569 | 27,950 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 34,532 | 1,875 |
| Prepaid expenses and other assets | 8,761 | 328 |
| Accounts payable | (5,644) | 4,856 |
| Accrued expenses | 6,854 | 1,843 |
| Operating lease, net | 890 | 1,374 |
| Other assets and liabilities, net | (6,071) | (5,893) |
| Net cash used in operating activities | (83,406) | (152,351) |
| Cash flows from investing activities | ||
| Purchase of marketable debt securities | (261,045) | (540,844) |
| Purchase of property and equipment | (2,010) | (4,433) |
| Purchase of patents | — | (2,396) |
| Proceeds from sales of marketable equity securities | 13,778 | 6,639 |
| Proceeds from sales and maturities of marketable debt securities | 318,089 | 475,910 |
| Net cash provided by (used in) investing activities | 68,812 | (65,124) |
| Cash flows from financing activities | ||
| Proceeds from the exercises of stock options | 2,974 | 2,612 |
| Proceeds from issuance of common stock under the Employee Stock Purchase Plan | 662 | 930 |
| Proceeds from issuance of common stock and pre-funded warrants | — | 201,256 |
| Common stock and pre-funded warrants issuance costs | — | (12,077) |
| Cash paid to acquire noncontrolling interest | (1,725) | — |
| Net cash provided by financing activities | 1,911 | 192,721 |
| Net decrease in cash, cash equivalents, and restricted cash | (12,683) | (24,754) |
| Cash, cash equivalents, and restricted cash, beginning of period | 41,262 | 54,170 |
| Cash, cash equivalents, and restricted cash, end of period | $28,579 | $29,416 |
| Supplemental disclosure of cash flow information | ||
| Interest paid | $4 | $31 |
| Income taxes paid | $7,359 | $6,100 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.